Aethlon Medical, Inc.

Symbol: AEMD

NASDAQ

2.02

USD

Market price today

  • -0.4346

    P/E Ratio

  • -0.0069

    PEG Ratio

  • 5.04M

    MRK Cap

  • 0.00%

    DIV Yield

Aethlon Medical, Inc. (AEMD) Stock Price & Analysis

Shares Outstanding

2.49M

Gross Profit Margin

-8036.64%

Operating Profit Margin

-20.74%

Net Profit Margin

-20.10%

Return on Assets

-0.90%

Return on Equity

-0.83%

Return on Capital Employed

-1.07%

Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. James B. Frakes M.B.A.
Full-time employees:15
City:San Diego
Address:11555 Sorrento Valley Road
IPO:1999-03-04
CIK:0000882291

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

General Outlook

In simple terms, Aethlon Medical, Inc. has 2.493 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep -8036.642% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -20.742%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -20.103%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.900% return, is a testament to Aethlon Medical, Inc.'s adeptness in optimizing resource deployment. Aethlon Medical, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.828%. Furthermore, the proficiency of Aethlon Medical, Inc. in capital utilization is underscored by a remarkable -1.071% return on capital employed.

Stock Prices

Aethlon Medical, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.19, while its low point bottomed out at $1.84. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Aethlon Medical, Inc.'s stock market.
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Aethlon Medical, Inc. (AEMD) on the NASDAQ in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -0.435 in 2023.

What is the ticker symbol of Aethlon Medical, Inc. stock?

The ticker symbol of Aethlon Medical, Inc. stock is AEMD.

What is company IPO date?

IPO date of Aethlon Medical, Inc. is 1999-03-04.

What is company current share price?

Current share price is 2.020 USD.

What is stock market cap today?

The market cap of stock today is 5035678.000.

What is PEG ratio in 2023?

The current -0.007 is -0.007 in 2023.

What is the number of employees in 2023?

In 2023 the company has 15.